Nadolol
NDC 69097-868, Nadolol, tablet, from Cipla USA Inc..
- Product NDC
- 69097-868
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203455
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-868 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NADOLOL40 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-868-02 | 69097086802 | 30 TABLET in 1 BOTTLE (69097-868-02) |
| 69097-868-07 | 69097086807 | 100 TABLET in 1 BOTTLE (69097-868-07) |
| 69097-868-15 | 69097086815 | 1000 TABLET in 1 BOTTLE (69097-868-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c899eedb-4113-45da-acc3-8e181250a7d8
Use it
Look up 69097-868 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-868 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-868. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.